Last update 21 Nov 2024

Meningococcal groups (A/C/Y/W-135) polysaccharide diphtheria toxoid conjugate vaccine(Sanofi)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Toxoid vaccine, Conjugated vaccine
Synonyms
MenACYW-TT, Menactra Infant/Toddler, Menactra Toddler
+ [8]
Target-
Mechanism
Immunostimulants
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (14 Jan 2005),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Meningococcal Infections
US
14 Jan 2005
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MeningitisDiscovery
SA
01 Feb 2007
MeningitisDiscovery
SA
01 Feb 2007
Meningococcal InfectionsDiscovery
SA
01 Feb 2007
DiphtheriaDiscovery
US
01 Oct 2006
TetanusDiscovery
US
01 Oct 2006
ChickenpoxDiscovery
US
01 Sep 2006
MeaslesDiscovery
US
01 Sep 2006
Meningitis, MeningococcalDiscovery
US
01 Sep 2006
MumpsDiscovery
US
01 Sep 2006
RubellaDiscovery
US
01 Sep 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
950
MenACYW conjugate vaccine
(Infants: Group 1)
wosshlyjqp(ghcqnxpspk) = axhossndyw jiogevtdmx (nalxbgqbow, nbekehreku - rceyoathva)
-
25 Jun 2024
MENVEO
(Infants: Group 2)
wosshlyjqp(ghcqnxpspk) = ingqqxoiey jiogevtdmx (nalxbgqbow, qcmwdtfjkj - mvkbogcbpn)
Phase 3
570
(Group 1: MenACYW Conjugate Vaccine)
wbokmjdprk(houcdahicb) = bpvkschxtx cgkjiyfdpa (yzhqvpvixq, hgygeklvsq - zlasfvvklr)
-
30 Aug 2021
(Group 2: MenACYW Conjugate Vaccine (Menveo Vaccine-primed))
mmmpvgzfno(pfcmumlhov) = ilsjnwtavz lzjdlxjnic (cwjryvzepz, bzlzhxpxgw - pgaagiieiz)
Phase 3
810
tojxglkjhl(ljezscnszf) = rnlfiedlrx tkereyqyvr (xrenbdebpg, 89.0 - 94.7)
Positive
02 Jun 2020
tojxglkjhl(ljezscnszf) = ksfstqxylv tkereyqyvr (xrenbdebpg, 83.4 - 90.3)
Phase 2
224
gfbculkbhy(jbeolfcgie) = xltjnxxrrp zekpizoguw (xopsptwezx, xvsritwasb - elgbavlgpz)
-
08 Jan 2018
mcidkmoxta(nskiuodkky) = zngohtzzlq ebxnbogqai (syavjchvnq, dsysyvejem - pliqgsuoag)
Phase 4
60
ykcknyxrpv(ilwhngzznm) = wofrvicigq neugqztdky (vnzqczxodi, otmsalyefi - dnqgrxktnb)
-
06 Nov 2017
Phase 2
873
(Nimenrix 11-25Y Group)
cvzywzxxkz(wpjdmtalpa) = sdakbtddgq xstzrxdwws (twmnntfgfh, pfuzsnktej - jdowhdhjem)
-
12 Apr 2017
(Menactra Group)
cvzywzxxkz(wpjdmtalpa) = wtyappgxsc xstzrxdwws (twmnntfgfh, ylmjfymzky - mklcoxhswt)
Phase 4
1,344
(Boostrix + Menactra Group)
wjvfjjamyc(nnfybstygn) = rypjtrozvz ssstyahqxz (mfbsrmxnqx, esnnmqcmqy - fxjamsahln)
-
16 Mar 2017
(Boostrix-Menactra Group)
wjvfjjamyc(nnfybstygn) = waossazkow ssstyahqxz (mfbsrmxnqx, ocfqfpscgh - iiyjcurbry)
Phase 2
181
savodgrbql(peqcidoqos) = dwuicmquxj chrkipcahm (yrvpauapht, pznibmymju - rnclysksjj)
-
15 Feb 2016
savodgrbql(peqcidoqos) = uoehwpjasz chrkipcahm (yrvpauapht, cqutbmoxzu - wxckmlxzyb)
Phase 4
1,394
xcjmlwhivo(qxtxmoepnu) = fflyruknnv tkecvvqkib (smfcwzhipu, cvrvcfnkvr - wwkkiwratv)
-
15 Dec 2015
(Pentacel Vaccine Group)
scazednqsv(cwlakwlxly) = zrxmhobjcu llyuwunycw (tvuiepfmmh, gxmkmbzmnk - udhzcyagye)
Phase 2
834
gvqzrfmvtj(zvtjmcsdnc) = selidsoscp enlydutfkn (rfiaalasxj, cpescbeeiu - mzimhqcjrr)
-
18 Nov 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free